Indo-Bangla Pharmaceuticals Limited (DSE: IBP)
Health Care · Pharmaceuticals · BD
Tk13.80
-5.48% today · +14.0% 1Y
Indo-Bangla Pharmaceuticals Limited (DSE: IBP) operates in the Pharmaceuticals industry within the Health Care sector. The company is valued at $13.02M.
Over the last twelve months the share price has gained 14.0%, trading between 10.00 and 21.40.
Tweenvest scores Indo-Bangla Pharmaceuticals Limited across four factors: quality 65/100, value 63/100, growth 0/100, dividend 9/100. Its strongest factor is quality.
IBP price history
Not enough price history to draw a chart yet.
Key figures
- Market cap
- $13.02M
- Revenue (TTM)
- $1.97M
- P/E
- —
- EPS
- -0.12
- Dividend yield
- 0.11%
- Beta (5Y)
- 0.19
- 52-week high
- Tk21.40
- 52-week low
- Tk10.00
- Avg volume (3M)
- —
- Shares outstanding
- 116.21M
- Employees
- —
- Next earnings
- —
Other Pharmaceuticals companies
| Company | Market cap | Price | Day |
|---|---|---|---|
| Lactose (India) LimitedBSE: 524202 | $13.52M | Rs103.95 | -1.38% |
| PT Phapros TbkIDX: PEHA | $13.52M | Rp288.00 | +2.86% |
| Klaria Pharma Holding AB (publ.)OM: KLAR | $13.36M | Skr0.54 | -8.12% |
| Ayr Wellness Inc.CNSX: AYR.A | $13.21M | CA$— | — |
| Silco Pharmaceuticals LimitedDSE: SILCOPHL | $12.90M | Tk15.30 | -8.38% |
| Anebulo Pharmaceuticals, Inc.OTCPK: ANEB | $12.85M | $0.32 | -1.56% |
| Intravenous Infusions PlcGHSE: IIL | $12.84M | GH₵0.55 | +12.24% |
| FLUENT Corp.CNSX: FNT.U | $12.76M | $0.02 | -20.00% |
Figures last refreshed Oct 11, 2026.